Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OK Providers

Dr. Philip C. Comp, MD

Accepting New Patients

(22 Ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of Oklahoma College of Medicine

Professional interests include: pulmonary embolism, hemochromatosis, anemia, and more.

Ou Health Stephenson Cancer Center - Transplant & Cellular Therapy .
Oklahoma City, OK 73104

1-800-NE1-0thS

Dr. Philip C. Comp, MD is a medical oncologist in Oklahoma City, OK specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Oklahoma College of Medicine. Dr. Philip C. Comp, MD is affiliated with OU Health, OU Health Stephenson Cancer Center and OU Health Stephenson Cancer Center - Transplant & Cellular Therapy Clinic.

Office Locations

800 Northeast 10th Street
Oklahoma City, OK 73104

open_in_new

OU Health Stephenson Cancer Center - Transplant & Cellular Therapy Clinic

Ou Health Stephenson Cancer Center - Transplant & Cellular Therapy .
Oklahoma City, OK 73104

1-800-NE1-0thS

open_in_new

Some issues Dr. Philip C. Comp, MD can help you with:

Anemia

Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.

An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.

Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.

Hemophilia

Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:

Presence of blood in stool or urine
Frequent nosebleeds or large bruises
Unusual bleeding after being vaccinated
Pain, swelling, or tightness in joint

Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.

Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.

Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.

Thrombocytopenia (Low Platelet Count)

Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.

If a doctor suspects a patient has a thrombocytopenia, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytopenia can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.

Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Many people with thrombocytopenia can live healthy and fulfilling lives with proper treatment and precautions.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Philip C. Comp, MD treated as a medical oncologist in Oklahoma City, OK during 2012 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and port flush.

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

biological response modifier (BRM) therapy	20
chemotherapy	20
doctor visit	101
minimally invasive procedures	20
port flush	15

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Philip C. Comp, MD treated as a medical oncologist in Oklahoma City, OK during 2013 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and port flush.

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

biological response modifier (BRM) therapy	24
chemotherapy	24
doctor visit	52
minimally invasive procedures	24
port flush	14

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	36
Female	54

**Ethnicity**
Non-Hispanic White	74
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	39
From 75 to 84	26
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2013

Hypertension	75
High Cholesterol	36
Stroke	0
Ischemic Heart Disease	42
Depression	18
Chronic Kidney Disease	23
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	14
Chronic Obstructive Pulmonary Disease	14
Diabetes	26
Dementia	0
Cancer	24

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Philip C. Comp, MD treated as a medical oncologist in Oklahoma City, OK during 2014 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and port flush.

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

biological response modifier (BRM) therapy	33
chemotherapy	33
doctor visit	63
minimally invasive procedures	33
port flush	30

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	45
Female	73

**Ethnicity**
Non-Hispanic White	94
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	69
From 75 to 84	22
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2014

Hypertension	64
High Cholesterol	34
Stroke	0
Ischemic Heart Disease	35
Depression	25
Chronic Kidney Disease	32
Asthma	0
Osteoperosis	10
Atrial Fibrilation	0
Heart Failure	16
Chronic Obstructive Pulmonary Disease	17
Diabetes	32
Dementia	0
Cancer	24

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Philip C. Comp, MD treated as a medical oncologist in Oklahoma City, OK during 2015 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and port flush.

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

biological response modifier (BRM) therapy	37
chemotherapy	37
doctor visit	68
minimally invasive procedures	37
port flush	30
preventive care	11
vaccines	11

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	94
Female	172

**Ethnicity**
Non-Hispanic White	196
Black	36
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	146
From 75 to 84	0
85 and over	0
Less than 65	62

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2015

Hypertension	63
High Cholesterol	33
Stroke	9
Ischemic Heart Disease	34
Depression	31
Chronic Kidney Disease	35
Asthma	14
Osteoperosis	0
Atrial Fibrilation	8
Heart Failure	22
Chronic Obstructive Pulmonary Disease	18
Diabetes	29
Dementia	0
Cancer	26

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Philip C. Comp, MD treated as a medical oncologist in Oklahoma City, OK during 2016 were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and port flush.

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

biological response modifier (BRM) therapy	56
chemotherapy	56
doctor visit	85
minimally invasive procedures	56
port flush	23

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	57
Female	116

**Ethnicity**
Non-Hispanic White	137
Black	17
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	88
From 75 to 84	0
85 and over	0
Less than 65	43

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2016

Hypertension	68
High Cholesterol	39
Stroke	0
Ischemic Heart Disease	34
Depression	25
Chronic Kidney Disease	37
Asthma	27
Osteoperosis	0
Atrial Fibrilation	10
Heart Failure	23
Chronic Obstructive Pulmonary Disease	21
Diabetes	35
Dementia	0
Cancer	33

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Philip C. Comp, MD treated as a medical oncologist in Oklahoma City, OK during 2017 were chemotherapy, biological response modifier (BRM) therapy and minimally invasive procedures.

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

biological response modifier (BRM) therapy	38
chemotherapy	38
doctor visit	58
minimally invasive procedures	38

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	58
Female	66

**Ethnicity**
Non-Hispanic White	94
Black	18
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	67
From 75 to 84	0
85 and over	0
Less than 65	29

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2017

Hypertension	67
High Cholesterol	40
Stroke	0
Ischemic Heart Disease	40
Depression	38
Chronic Kidney Disease	41
Asthma	0
Osteoperosis	0
Atrial Fibrilation	11
Heart Failure	18
Chronic Obstructive Pulmonary Disease	23
Diabetes	36
Dementia	11
Cancer	29

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

doctor visit	20

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	15
Female	16

**Age**
From 65 to 74	13
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2018

Hypertension	65
High Cholesterol	55
Stroke	0
Ischemic Heart Disease	45
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	42
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

doctor visit	23

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	14
Female	16

**Age**
From 65 to 74	12
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2019

Hypertension	57
High Cholesterol	70
Stroke	0
Ischemic Heart Disease	40
Depression	0
Chronic Kidney Disease	40
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	40
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

doctor visit	28

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	14
Female	16

**Age**
From 65 to 74	14
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2020

Hypertension	67
High Cholesterol	53
Stroke	0
Ischemic Heart Disease	40
Depression	0
Chronic Kidney Disease	43
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

doctor visit	12

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	15
Female	15

**Age**
From 65 to 74	16
From 75 to 84	0
85 and over	0
Less than 65	0

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2021

Hypertension	60
High Cholesterol	37
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	37
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

doctor visit	14

Conditions of Medicare patients treated by Dr. Philip C. Comp, MD in 2022

Hypertension	71
High Cholesterol	63
Stroke	0
Ischemic Heart Disease	0
Depression	0
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Philip C. Comp, MD for Medicare patients.

The highest averages for the top procedures that Dr. Philip C. Comp, MD treated as a medical oncologist in Oklahoma City, OK were chemotherapy, biological response modifier (BRM) therapy, minimally invasive procedures and preventive care.

biological response modifier (BRM) therapy	34
chemotherapy	34
doctor visit	47
minimally invasive procedures	34
preventive care	11
vaccines	11

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Philip C. Comp, MD.

**Gender**
Male	31
Female	49

**Ethnicity**
Black / African American	6
Asian / Pacific Islander	0
Non-Hispanic White	54
Native American / Alaskan Native	0
Hispanic	0
Other	0

**Age**
75 to 84	4
85 and over	0
Less than 65	12
65 to 74	42

Average of Total of Conditions of Medicare patients treated by Dr. Philip C. Comp, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Philip C. Comp, MD treated were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.

Hypertension	59
High Cholesterol	41
Stroke	0
Ischemic Heart Disease	28
Depression	12
Chronic Kidney Disease	26
Asthma	3
Osteoporosis	0
Heart Failure	8
Chronic Obstructive Pulmonary Disease	8
Diabetes	21
Atrial Fibrillation	2
Dementia	1
Cancer	12

Education & Training

Dr. Philip C. Comp, MD graduated from University of Oklahoma College of Medicine. He completed residency at University of Pennsylvania Affiliated Hospitals. He has a state license in Oklahoma.

Medical School: University of Oklahoma College of Medicine

Residency: University of Pennsylvania Affiliated Hospitals (1974)

Licensed In: Oklahoma

Affiliations & Hospitals

Dr. Philip C. Comp, MD is associated with these hospitals and organizations:

OU Health

OU Health Stephenson Cancer Center

OU Health Stephenson Cancer Center - Transplant & Cellular Therapy Clinic

Ratings & Reviews

Dr. Philip C. Comp, MD has an exceptional overall rating with an average of 5.0 out of 5 stars based on 22 ratings. We collect ratings and reviews of Dr. Philip C. Comp, MD from all over the web to help you find the right in Oklahoma City, OK.

Overall Rating

(22 Ratings)

Leave a Review

Reviews From Around The Web

Overall Rating: 5.0 2025-12-18

Patient verified via Press Ganey

Our dr was very pleasant, made sure we knew if we had any questions to reach out to him so he could answer.

Overall Rating: 5.0 2024-05-05

Patient verified via Press Ganey

Dr Comp is thorough and compassionate

Overall Rating: 5.0 2025-08-24

Patient verified via Press Ganey

Everything was good nice people

Overall Rating: 5.0 2024-04-24

Patient verified via Press Ganey

They are amazing team.

General Payments

These charts describe general payments received by Dr. Philip C. Comp, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Boehringer Ingelheim Pharmaceuticals, Inc.	$12,901 Pradaxa $12,901
E.R. Squibb & Sons, L.L.C.	$7,319 ELIQUIS $7,310	$9
Janssen Pharmaceuticals, Inc	$4,764 XARELTO $4,764
Pfizer Inc.	$3,719 ELIQUIS $3,665	$54
Incyte Corporation	$264 JAKAFI $158	$107
Other	$1,602 Albutein $145	ABSORB $118	HeartMate $117	ADVATE $112	ULTOMIRIS $104	Other $1,006

**Types of Payments**
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$23,550
Food and Beverage	$2,875
Travel and Lodging	$2,327
Consulting Fee	$1,750
Education	$66

Biography

Dr. Philip Comp is a specialist in adult hematology, adult oncology, and medical oncology. He works in Oklahoma City, OK. He has a 5.0 out of 5 star average patient rating. Dr. Comp's clinical interests include anemia, pulmonary embolism, and venous thrombosis. His education and training includes medical school at the University of Washington School of Medicine and the University of Oklahoma College of Medicine and residency at a hospital affiliated with the University of Pennsylvania. He has received the following distinctions: Internal Medicine Award for Superior Teaching; James F. Hammarsten Physician of Excellence; and Award. Dr. Comp is professionally affiliated with OU Health. He has an open panel in Oklahoma City, OK according to Doctor.com.